Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Trojano, Maria ^a   Lucchese, Guglielmo ^a   Graziano, Giusi ^b   Taylor, Bruce V ^c   Simpson, Steve ^c   Lepore, Vito ^b   Grand'Maison, Francois ^d   Duquette, Pierre ^e   Izquierdo, Guillermo ^f   Grammond, Pierre ^g   Amato, Maria Pia ^h   Bergamaschi, Roberto ⁱ   Giuliani, Giorgio ^j   Boz, Cavit ^k   Hupperts, Raymond ^l   Van Pesch, Vincent ^m   Lechner Scott, Jeannette ⁿ   Cristiano, Edgardo ^o   Fiol, Marcela ^p   Oreja Guevara, Celia ^q   Saladino, Maria Laura ^r   Verheul, Freek ^s   Slee, Mark ^t   Paolicelli, Damiano ^a   Tortorella, Carla ^a   D'Onghia, Mariangela ^a   Iaffaldano, Pietro ^a   Direnzo, Vita ^a   Butzkueven, Helmut ^u,v,w   Pearson, John F ^x   Clarke, Glynnis ^x   Abernathy, David A ^y   Mason, Deborah F ^z   Willoughby, Ernie ^aa   Sabel, Clive ^ab   more..

^a UNIVERSITY OF BARI   (Italy)

^b Consorzio Mario Negri Sud ^*  (Italy)

^c UNIVERSITY OF TASMANIA   (Australia)

^d HÔPITAL CHARLES LEMOYNE   (Canada)

^e NOTRE DAME HOSPITAL   (Canada)

^f HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^g Hotel Dieu de Levis Hospital   (Canada)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^j Ospedale di Macerata   (Italy)

^k KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^l Sittard Geleen Heerlen   (Netherlands)

^m CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

ⁿ JOHN HUNTER HOSPITAL   (Australia)

^o HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^p FLENI   (Argentina)

^q HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^r INEBA ^*  (Argentina)

^s Groen Hart Ziekenhuis   (Netherlands)

^t FLINDERS UNIVERSITY   (Australia)

^u ROYAL MELBOURNE HOSPITAL   (Australia)

^v UNIVERSITY OF MELBOURNE   (Australia)

^w MONASH UNIVERSITY   (Australia)

^x UNIVERSITY OF OTAGO   (New Zealand)

^y UNIVERSITY OF OTAGO   (New Zealand)

^z CHRISTCHURCH HOSPITAL   (New Zealand)

^aa AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^ab UNIVERSITY OF EXETER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868131395     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048078     Document Type: Article

References (45)

1. International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple Sclerosis. Nature. Aug 10 476(7359): 214-9.
2. Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. PartI: the role of infection. Ann Neurol. Apr;61(4): 288-99. Review. (a).
3. Ascherio A, Munger KL, (2007) Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 61: 504-13 (b).
4. Hedström AK, Sundqvist E, Bäärnhielm M, Nordin N, Hillert J, et al. (2011) Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain. Mar;134(Pt 3): 653-64.
5. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, et al. (2009) Expression of the multiple sclerosis-associated MHC class II Allele HLADRB1* 1501 is regulated by vitamin D. PLoS Genet. Feb 5(2): e1000369.
6. Koch-Henriksen N, Sorensen PS, (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. May 9(5): 520-32.
7. Alonso A, Hernan MA, (2008) Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology. Jul 8 71(2): 129-35.
8. Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, et al. (2005) Changes in the ascertainment of multiple sclerosis. Neurology. Oct 11 65(7): 1066-70.
9. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. Jul 50(1): 121-7.
10. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. Dec 58(6): 840-6.
11. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, et al. (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. Nov 5(11): 932-6.
12. Sadovnick AD, (2009) European Charcot Foundation Lecture: the natural history of multiple sclerosis and gender. J Neurol Sci. Nov 15 286(1-2): 1-5.
13. Osoegawa M, Kira J, Fukazawa T, Fujihara K, Kikuchi S, et al. (2009) Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler 15: 159-73.
14. Bentzen J, Flachs EM, Stenager E, Brønnum-Hansen H, Koch-Henriksen N, (2010) Prevalence of multiple sclerosis in Denmark 1950-2005.Mult. Scler (16): 520-5.
15. Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, et al. (2010) Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol 64: 331-6.
16. Debouverie M, Pittion-Vouyovitch S, Louis S, Roederer T, Guillemin F, (2007) Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France. Mult Scler. Sep 13(8): 962-7.
17. Celius EG, Smestad C (2009) Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades. Acta Neurol Scand Suppl. (189): 27-9.
18. Maghzi AH, Ghazavi H, Ahsan M, Etemadifar M, Mousavi S, et al. (2010) Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler. Mar 16(3): 359-61.
19. Ramagopalan SV, Byrnes JK, Orton SM, Dyment DA, Guimond C, et al. (2010) Sex ratio of multiple sclerosis and clinical phenotype. Eur J Neurol. Apr 17(4): 634-7.
20. Taylor BV, Pearson JF, Clarke G, Mason DF, Abernethy DA, et al. (2010) MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler. Dec 16(12): 1422-31.
21. Simpson S Jr, Pittas F, van der Mei I, Blizzard L, Ponsonby AL, et al. (2011) Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009. J Neurol Neurosurg Psychiatry. 82: 180-7.
22. Hurwitz BJ, (2011) Registry studies of long-term multiple sclerosis outcomes: description of key registries. Neurology. Jan 4 76(1Suppl 1): S3-6.
23. Butzkueven H, Chapman J, Cristiano E, Grand'Maison F, Hoffmann M, et al. (2006) MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult Scler. Dec 12(6): 769-74.
24. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. Mar 13(3): 227-31.
25. Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, et al. (2012) Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada. J Neurol Neurosurg Psychiatry. Jan 83(1): 61-6.
26. Glad SB, Nyland HI, Aarseth JH, Riise T, Myhr KM, (2009) Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway. Mult Scler (15) (): 942-50.
27. Sellner J, Kraus J, Awad A, Milo R, Hemmer B, et al. (2011) The increasing incidence and prevalence of female multiple sclerosis-A critical analysis of potential environmental factors. Autoimmun Rev. Jun 10(8): 495-502.
28. Orton SM, Ramagopalan SV, Brocklebank D, Herrera BM, Dyment DA, et al. (2010) Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study. J Neurol Neurosurg Psychiatry. Jan 81(1): 31-6.
29. McDowell TY, Amr S, Culpepper WJ, Langenberg P, Royal W, et al. (2011) Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis. Neuroepidemiology. 36(1): 39-45.
30. Orton SM, Wald L, Confavreux C, Vukusic S, Krohn JP, et al. (2011) Association of UV radiation with multiple sclerosis prevalence and sex ratio in France. Neurology. Feb 1 76(5): 425-31.
31. Ramagopalan SV, Handel AE, Giovannoni G, Rutherford Siegel S, Ebers GC, et al. (2011) Relationship of UV exposure to prevalence of multiple sclerosis in England. Neurology. Apr 19 76(16): 1410-4.
32. Islam T, Gauderman WJ, Cozen W, Mack TM, (2007) Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology. Jul 24 69(4): 381-8.
33. Moussavi M, Heidarpour R, Aminorroaya A, Pournaghshband Z, Amini M, (2005) Prevalence of vitamin D deficiency in Isfahani high school students in 2004. Horm Res. 64(3): 144-8.
34. Correale J, Ysrraelit MC, Gaitán MI, (2009) Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. May;132(Pt 5): 1146-60.
35. Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, et al. (2009) Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler. Jan 15(1): 9-15.
36. Correale J, Ysrraelit MC, Gaitan MI, (2010) Gender differences in 1, 25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol (185): 4948-58.
37. Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, et al. (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 68(2): 193-203.
38. Guzel R, Kozanoglu E, Guler-Uysal F, Soyupak S, Sarpel T, (2001) Vitamin D status and bone mineral density of veiled and unveiled Turkish women. J Womens Health Gend Based Med. Oct 10(8): 765-70.
39. Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, et al. (2011) Smoking and multiple sclerosis: an updated meta-analysis. PLoS One. Jan 13 6(1): e16149.
40. Palacios N, Alonso A, Bronum-Hansen H, Ascherio A, (2011) Smoking and Increased Risk of Multiple Sclerosis: Parallel Trends in the Sex Ratio Reinforce the Evidence. Ann Epidemiol. 21: 536-542.
41. Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, et al. (2010) An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One. Sep 1;5(9). pii: e12496.
42. El-Etr M, Ghoumari A, Sitruk-Ware R, Schumacher M, (2011) Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids. Maturitas. Jan 68(1): 47-51.
43. Massilamany C, Thulasingam S, Steffen D, Reddy J, (2011) Gender differences in CNS autoimmunity induced by mimicry epitope for PLP 139-151 in SJL mice. J Neuroimmunol. Jan 230(1-2): 95-104.
44. Chao MJ, Ramagopalan SV, Herrera BM, Orton SM, Handunnetthi L, et al. (2011) MHC transmission: insights into gender bias in MS susceptibility. Neurology. Jan 18 76(3): 242-6.